PLCE1 Is a Poor Prognostic Marker and May Promote Immune Escape from Osteosarcoma by the CD70-CD27 Signaling Pathway. Biomol Biomed 2022, 22 (6), 992-1004. https://doi.org/10.17305/bjbms.2022.7416.